2024 연구자 정보 (8 / 1073)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Park, Taiho (Park, T) |
교신저자 | Pohang Univ Sci & Technol POSTECH, Dept Chem Engn, 77 Cheongam Ro, Pohang 37673, Gyeongbuk, South Korea |
M-9271-2018 Park, Taiho |
0000-0002-5867-4679 Park, Taiho |
[JCR상위 0.4%] Understanding charge carrier dynamics in organic photocatalysts for hydrogen evolution | SCIE | 0.4 |
CHEMISTRY, MULTIDISCIPLINARY ENERGY & FUELS ENGINEERING, CHEMICAL ENVIRONMENTAL SCIENCES |
hcha@knu.ac.kr taihopark@postech.ac.kr |
|
|
Al-Ahmadie, Hikmat (Al-Ahmadie, H) |
Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, 1275 York Ave, New York, NY 10021 USA |
|
0000-0002-2938-6627 Al-Ahmadie, Hikmat |
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Antonuzzo, Lorenzo (Antonuzzo, L) |
Univ Florence, Dept Expt & Clin Med, Florence, Italy Careggi Univ Hosp, Med Oncol Unit, Florence, Italy |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Armstrong, Jon (Armstrong, J) |
AstraZeneca, Cambridge, England |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Atduev, Vagif (Atduev, V) |
Fed Med Biol Agcy, Volga Dist Med Ctr, Nizhnii Novgorod, Russia |
V-3467-2017 Atduev, Vagf |
0000-0003-4478-7282 Atduev, Vagif |
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Barnett, Anastasia (Barnett, A) |
Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA |
|
|
[JCR상위 0.5%] The hippocampal CA2 region discriminates social threat from social safety | SCIE | 0.5 | NEUROSCIENCES | pegahkf@gmail.com | ||
|
Bhosale, Reshma (Bhosale, R) |
Savitribai Phule Pune Univ, Dept Environm Sci, Pune 411007, Maharashtra, India |
|
|
[JCR상위 0.5%] Defect-enriched BiOIO 3 /Ti3C2 MXene 2D/2D Schottky-type heterostructure for efficient and selective CH 4 production via CO 2 photoreduction: Unveiling the roles of defect inclusion and Ti3 C2 MXene co-catalyst | SCIE | 0.5 |
MATERIALS SCIENCE, MULTIDISCIPLINARY METALLURGY & METALLURGICAL ENGINEERING |
wkjo@knu.ac.kr surendart@knu.ac.kr |
||
|
Bigler, Shivani K. (Bigler, SK) |
Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA |
|
0000-0002-3342-1843 Bigler, Shivani |
[JCR상위 0.5%] The hippocampal CA2 region discriminates social threat from social safety | SCIE | 0.5 | NEUROSCIENCES | pegahkf@gmail.com | ||
|
Buchler, Tomas (Buchler, T) |
Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic Thomayer Hosp, Prague, Czech Republic |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Catto, James W. F. (Catto, JWF) |
Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, S Yorkshire, England Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Chang, Chao-Hsiang (Chang, CH) |
China Med Univ Hosp, Dept Urol, Taichung, Taiwan China Med Univ, Coll Chinese Med, Sch Med, Taichung, Taiwan |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Choi, Bum-Sung (Choi, BS) |
|
|
[JCR상위 0.5%] PROBABILITY OF TRANSITION TO PSYCHOSIS IN INDIVIDUALS WITH NEURODEVELOPMENTAL DISORDERS |
SCIE SSCI |
0.5 |
PEDIATRICS PSYCHOLOGY, DEVELOPMENTAL PSYCHIATRY |
tylee.knu@gmail.com | |||
|
Eigl, Bernhard J. (Eigl, BJ) |
BC Canc Vancouver, Vancouver, BC, Canada |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Gadot, Moran (Gadot, M) |
Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net | ||
|
Galsky, Matthew D. (Galsky, MD) |
Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA |
|
|
[JCR상위 0.5%] Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | SCIE | 0.5 | MEDICINE, GENERAL & INTERNAL | thomas.powles1@nhs.net |
페이지 이동: